1,2-dichloroethane decreases expression ISO RGD:1316587 6480464 ethylene dichloride results in decreased expression of CXCL14 mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:1316587 6480464 1, 2-Dimethylhydrazine results in increased expression of CXCL14 mRNA CTD PMID:22206623 1,3-benzothiazole-2-thiol decreases expression ISO RGD:1316586 6480464 captax results in decreased expression of CXCL14 mRNA, captax results in decreased expression of CXCL14 protein CTD PMID:31734321 1,4-phenylenediamine decreases expression ISO RGD:1316586 6480464 4-phenylenediamine results in decreased expression of CXCL14 protein CTD PMID:31734321 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1316587 6480464 Dinitrochlorobenzene results in increased expression of CXCL14 mRNA CTD PMID:19647056 1-chloro-2,4-dinitrobenzene decreases expression ISO RGD:1316586 6480464 Dinitrochlorobenzene results in decreased expression of CXCL14 protein CTD PMID:31734321 17alpha-ethynylestradiol multiple interactions ISO RGD:1316587 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CXCL14 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CXCL14 mRNA CTD PMID:17351261 17beta-estradiol multiple interactions ISO RGD:1316586 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of CXCL14 mRNA more ... CTD PMID:17404688 more ... 17beta-estradiol increases expression ISO RGD:1316587 6480464 Estradiol results in increased expression of CXCL14 mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO RGD:1316586 6480464 Estradiol results in increased expression of CXCL14 mRNA CTD PMID:18191855 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1316587 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1316587 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CXCL14 mRNA, AHRR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CXCL14 mRNA] CTD PMID:17942748 , PMID:26862745 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1316587 6480464 Tetrachlorodibenzodioxin affects the expression of CXCL14 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1316587 6480464 Tetrachlorodibenzodioxin results in increased expression of CXCL14 mRNA CTD PMID:26862745 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1316586 6480464 Tetrachlorodibenzodioxin results in decreased expression of CXCL14 mRNA CTD PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CXCL14 mRNA CTD PMID:20959002 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CXCL14 mRNA CTD PMID:21215274 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1316586 6480464 Tetrachlorodibenzodioxin affects the expression of CXCL14 mRNA CTD PMID:22298810 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1316587 6480464 Trinitrobenzenesulfonic Acid results in increased expression of CXCL14 mRNA CTD PMID:15973123 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CXCL14 mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20959002 3-Nitrobenzanthrone increases expression ISO RGD:1316586 6480464 3-nitrobenzanthrone results in increased expression of CXCL14 mRNA CTD PMID:19879285 3-phenylprop-2-enal increases expression ISO RGD:1316586 6480464 cinnamaldehyde results in increased expression of CXCL14 mRNA CTD PMID:30806763 4,4'-diaminodiphenylmethane increases expression ISO RGD:1316587 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CXCL14 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases expression ISO RGD:1316587 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of CXCL14 mRNA CTD PMID:30951980 , PMID:32071231 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1316587 6480464 Oxazolone results in increased expression of CXCL14 mRNA CTD PMID:19647056 4-hydroxy-TEMPO decreases expression ISO RGD:1316587 6480464 tempol results in decreased expression of CXCL14 mRNA CTD PMID:19555370 4-hydroxynon-2-enal decreases expression ISO RGD:1316587 6480464 4-hydroxy-2-nonenal results in decreased expression of CXCL14 mRNA CTD PMID:19191707 5-aza-2'-deoxycytidine decreases methylation ISO RGD:1316586 6480464 Decitabine results in decreased methylation of CXCL14 promoter CTD PMID:20562917 5-aza-2'-deoxycytidine increases expression ISO RGD:1316586 6480464 Decitabine results in increased expression of CXCL14 mRNA CTD PMID:20562917 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CXCL14 mRNA CTD PMID:24780913 9-cis-retinoic acid decreases expression EXP 6480464 Alitretinoin results in decreased expression of CXCL14 mRNA CTD PMID:16648578 aflatoxin B1 increases expression ISO RGD:1316586 6480464 Aflatoxin B1 results in increased expression of CXCL14 mRNA CTD PMID:22100608 all-trans-retinoic acid decreases expression ISO RGD:1316586 6480464 Tretinoin results in decreased expression of CXCL14 mRNA CTD PMID:21934132 alpha-hexylcinnamaldehyde decreases expression ISO RGD:1316586 6480464 hexyl cinnamic aldehyde results in decreased expression of CXCL14 protein CTD PMID:31734321 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CXCL14 mRNA CTD PMID:16483693 arsenite(3-) multiple interactions ISO RGD:1316587 6480464 TRP53 protein affects the reaction [arsenite results in increased expression of CXCL14 mRNA] CTD PMID:18929588 arsenite(3-) decreases methylation ISO RGD:1316586 6480464 arsenite results in decreased methylation of CXCL14 promoter CTD PMID:23974009 arsenite(3-) increases expression ISO RGD:1316587 6480464 arsenite results in increased expression of CXCL14 mRNA CTD PMID:18929588 arsenous acid decreases expression ISO RGD:1316586 6480464 Arsenic Trioxide results in decreased expression of CXCL14 mRNA CTD PMID:26705709 belinostat increases expression ISO RGD:1316586 6480464 belinostat results in increased expression of CXCL14 mRNA CTD PMID:26272509 benzo[a]pyrene decreases expression ISO RGD:1316587 6480464 Benzo(a)pyrene results in decreased expression of CXCL14 mRNA CTD PMID:25908611 benzo[a]pyrene increases methylation ISO RGD:1316586 6480464 Benzo(a)pyrene results in increased methylation of CXCL14 promoter CTD PMID:27901495 Benzo[k]fluoranthene increases expression ISO RGD:1316587 6480464 benzo(k)fluoranthene results in increased expression of CXCL14 mRNA CTD PMID:26377693 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of CXCL14 mRNA CTD PMID:16648578 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CXCL14 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1316587 6480464 bisphenol A results in decreased expression of CXCL14 mRNA CTD PMID:26911702 , PMID:32071231 bisphenol A increases expression ISO RGD:1316587 6480464 bisphenol A results in increased expression of CXCL14 mRNA CTD PMID:25594700 bisphenol F decreases expression ISO RGD:1316587 6480464 bisphenol F results in decreased expression of CXCL14 mRNA CTD PMID:30951980 bleomycin A2 increases expression ISO RGD:1316587 6480464 Bleomycin results in increased expression of CXCL14 mRNA CTD PMID:36087614 butanal increases expression ISO RGD:1316586 6480464 butyraldehyde results in increased expression of CXCL14 mRNA CTD PMID:26079696 cadmium atom decreases expression ISO RGD:1316586 6480464 Cadmium results in decreased expression of CXCL14 mRNA CTD PMID:21120746 calcitriol decreases expression ISO RGD:1316586 6480464 Calcitriol results in decreased expression of CXCL14 mRNA CTD PMID:16002434 cannabidiol decreases expression ISO RGD:1316587 6480464 Cannabidiol results in decreased expression of CXCL14 mRNA CTD PMID:21542829 carbon nanotube decreases expression ISO RGD:1316587 6480464 Nanotubes more ... CTD PMID:25620056 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of CXCL14 mRNA CTD PMID:18500788 chloromethylisothiazolinone multiple interactions ISO RGD:1316586 6480464 [5-chloro-2-methyl-4-isothiazolin-3-one co-treated with 2-methyl-4-isothiazolin-3-one] results in decreased expression of CXCL14 protein CTD PMID:31734321 choline multiple interactions ISO RGD:1316587 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CXCL14 mRNA CTD PMID:20938992 cisplatin increases expression ISO RGD:1316586 6480464 Cisplatin results in increased expression of CXCL14 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:1316586 6480464 cobaltous chloride results in decreased expression of CXCL14 protein CTD PMID:31734321 copper atom decreases expression EXP 6480464 Copper results in decreased expression of CXCL14 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of CXCL14 mRNA CTD PMID:30556269 curcumin decreases expression ISO RGD:1316587 6480464 Curcumin results in decreased expression of CXCL14 mRNA CTD PMID:19555370 decabromodiphenyl ether multiple interactions EXP 6480464 [Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in decreased expression of CXCL14 mRNA CTD PMID:32207525 dextran sulfate multiple interactions ISO RGD:1316587 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL14 mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO RGD:1316586 6480464 Arsenic Trioxide results in decreased expression of CXCL14 mRNA CTD PMID:26705709 dichloroacetic acid decreases expression ISO RGD:1316587 6480464 Dichloroacetic Acid results in decreased expression of CXCL14 mRNA CTD PMID:28962523 diclofenac increases expression ISO RGD:1316587 6480464 Diclofenac results in increased expression of CXCL14 mRNA CTD PMID:26934552 diethylstilbestrol increases expression ISO RGD:1316587 6480464 Diethylstilbestrol results in increased expression of CXCL14 mRNA CTD PMID:17394237 dimethyl sulfoxide affects expression ISO RGD:1316586 6480464 Dimethyl Sulfoxide affects the expression of CXCL14 mRNA CTD PMID:24834073 dimethylarsinous acid increases expression ISO RGD:1316586 6480464 dimethylarsinous acid results in increased expression of CXCL14 mRNA CTD PMID:20886546 dioxygen multiple interactions ISO RGD:1316587 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL14 mRNA CTD PMID:30529165 diuron increases expression EXP 6480464 Diuron results in increased expression of CXCL14 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1316586 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:1316587 6480464 epoxiconazole results in decreased expression of CXCL14 mRNA CTD PMID:35436446 ethylene glycol dimethacrylate decreases expression ISO RGD:1316586 6480464 ethylene dimethacrylate results in decreased expression of CXCL14 protein CTD PMID:31734321 fenvalerate decreases expression EXP 6480464 fenvalerate results in decreased expression of CXCL14 mRNA CTD PMID:30307764 flutamide increases expression EXP 6480464 Flutamide results in increased expression of CXCL14 mRNA CTD PMID:21525395 folic acid multiple interactions ISO RGD:1316587 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CXCL14 mRNA CTD PMID:20938992 fonofos increases methylation ISO RGD:1316586 6480464 Fonofos results in increased methylation of CXCL14 promoter CTD PMID:22847954 fumonisin B1 multiple interactions ISO RGD:1316587 6480464 [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of CXCL14 mRNA, [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of CXCL14 mRNA CTD PMID:30448865 genistein decreases expression ISO RGD:1316586 6480464 Genistein results in decreased expression of CXCL14 mRNA CTD PMID:15256057 indometacin increases expression ISO RGD:1316586 6480464 Indomethacin results in increased expression of CXCL14 mRNA CTD PMID:24737281 iron(2+) sulfate (anhydrous) decreases expression ISO RGD:1316586 6480464 ferrous sulfate results in decreased expression of CXCL14 mRNA CTD PMID:19428942 L-methionine multiple interactions ISO RGD:1316587 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CXCL14 mRNA CTD PMID:20938992 lipopolysaccharide increases expression ISO RGD:1316586 6480464 Lipopolysaccharides results in increased expression of CXCL14 mRNA CTD PMID:19428942 lycopene decreases expression ISO RGD:1316587 6480464 lycopene results in decreased expression of CXCL14 mRNA CTD PMID:19555370 manganese atom increases expression ISO RGD:1316586 6480464 Manganese results in increased expression of CXCL14 mRNA CTD PMID:17175027 manganese(0) increases expression ISO RGD:1316586 6480464 Manganese results in increased expression of CXCL14 mRNA CTD PMID:17175027 manganese(II) chloride increases expression ISO RGD:1316586 6480464 manganese chloride results in increased expression of CXCL14 mRNA CTD PMID:17175027 mercury dibromide increases expression ISO RGD:1316586 6480464 mercuric bromide results in increased expression of CXCL14 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1316586 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA CTD PMID:27188386 methotrexate affects expression ISO RGD:1316587 6480464 Methotrexate affects the expression of CXCL14 mRNA CTD PMID:18502557 methyl methacrylate decreases expression ISO RGD:1316586 6480464 Methylmethacrylate results in decreased expression of CXCL14 protein CTD PMID:31734321 methylisothiazolinone multiple interactions ISO RGD:1316586 6480464 [5-chloro-2-methyl-4-isothiazolin-3-one co-treated with 2-methyl-4-isothiazolin-3-one] results in decreased expression of CXCL14 protein CTD PMID:31734321 methylisothiazolinone increases expression ISO RGD:1316586 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of CXCL14 mRNA CTD PMID:30806763 , PMID:31629900 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of CXCL14 mRNA CTD PMID:31378766 N-Acetyl-S-(1,2-dichlorovinyl)-cysteine affects expression ISO RGD:1316586 6480464 S-1, 2-dichlorovinyl-N-acetylcysteine affects the expression of CXCL14 mRNA CTD PMID:16844155 N-nitrosodiethylamine increases expression ISO RGD:1316587 6480464 Diethylnitrosamine results in increased expression of CXCL14 mRNA CTD PMID:24535843 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of CXCL14 mRNA CTD PMID:19716841 naphthalene increases expression ISO RGD:1316587 6480464 naphthalene results in increased expression of CXCL14 mRNA CTD PMID:18978301 nickel dichloride decreases expression ISO RGD:1316586 6480464 nickel chloride results in decreased expression of CXCL14 protein CTD PMID:31734321 O-acetyl-L-carnitine decreases expression ISO RGD:1316587 6480464 Acetylcarnitine results in decreased expression of CXCL14 mRNA CTD PMID:19555370 ozone decreases expression ISO RGD:1316587 6480464 Ozone results in decreased expression of CXCL14 mRNA CTD PMID:12763052 ozone multiple interactions ISO RGD:1316587 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CXCL14 mRNA CTD PMID:34911549 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of CXCL14 mRNA CTD PMID:18754875 panobinostat multiple interactions ISO RGD:1316586 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1316586 6480464 panobinostat results in increased expression of CXCL14 mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:1316587 6480464 Acetaminophen affects the expression of CXCL14 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CXCL14 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1316587 6480464 Acetaminophen results in increased expression of CXCL14 mRNA, Acetaminophen results in increased expression of CXCL14 protein CTD PMID:34724096 paracetamol multiple interactions ISO RGD:1316587 6480464 SB 225002 inhibits the reaction [Acetaminophen results in increased expression of CXCL14 protein] CTD PMID:34724096 paraquat decreases expression ISO RGD:1316586 6480464 Paraquat results in decreased expression of CXCL14 mRNA CTD PMID:35182771 parathion increases methylation ISO RGD:1316586 6480464 Parathion results in increased methylation of CXCL14 promoter CTD PMID:22847954 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CXCL14 mRNA CTD PMID:19162173 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CXCL14 mRNA CTD PMID:19162173 phenyl benzoate decreases expression ISO RGD:1316586 6480464 diphenylcarboxylate results in decreased expression of CXCL14 protein CTD PMID:31734321 phenylmercury acetate increases expression ISO RGD:1316586 6480464 Phenylmercuric Acetate results in increased expression of CXCL14 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1316586 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:1316587 6480464 pirinixic acid results in increased expression of CXCL14 mRNA CTD PMID:16985257 pirinixic acid decreases expression ISO RGD:1316587 6480464 pirinixic acid results in decreased expression of CXCL14 mRNA CTD PMID:23811191 progesterone affects expression ISO RGD:1316587 6480464 Progesterone affects the expression of CXCL14 mRNA CTD PMID:17251523 progesterone increases expression ISO RGD:1316586 6480464 Progesterone results in increased expression of CXCL14 mRNA CTD PMID:19903701 progesterone multiple interactions ISO RGD:1316586 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of CXCL14 mRNA more ... CTD PMID:17404688 more ... propanal increases expression ISO RGD:1316586 6480464 propionaldehyde results in increased expression of CXCL14 mRNA CTD PMID:26079696 resveratrol decreases expression ISO RGD:1316587 6480464 resveratrol results in decreased expression of CXCL14 mRNA CTD PMID:19555370 SB 431542 multiple interactions ISO RGD:1316586 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CXCL14 mRNA CTD PMID:32721576 silver atom affects expression ISO RGD:1316587 6480464 Silver affects the expression of CXCL14 mRNA CTD PMID:27131904 silver(0) affects expression ISO RGD:1316587 6480464 Silver affects the expression of CXCL14 mRNA CTD PMID:27131904 sodium arsenate increases expression ISO RGD:1316587 6480464 sodium arsenate results in increased expression of CXCL14 mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO RGD:1316586 6480464 sodium arsenite results in decreased expression of CXCL14 mRNA CTD PMID:20886546 sodium arsenite increases expression ISO RGD:1316586 6480464 sodium arsenite results in increased expression of CXCL14 mRNA CTD PMID:34032870 sodium dodecyl sulfate decreases expression ISO RGD:1316586 6480464 Sodium Dodecyl Sulfate results in decreased expression of CXCL14 mRNA, Sodium Dodecyl Sulfate results in decreased expression of CXCL14 protein CTD PMID:31734321 sodium dodecyl sulfate multiple interactions ISO RGD:1316586 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sodium Dodecyl Sulfate results in decreased expression of CXCL14 protein], WHI P131 inhibits the reaction [Sodium Dodecyl Sulfate results in decreased expression of CXCL14 protein] CTD PMID:31734321 terbufos increases methylation ISO RGD:1316586 6480464 terbufos results in increased methylation of CXCL14 promoter CTD PMID:22847954 tetrachloromethane increases expression ISO RGD:1316587 6480464 Carbon Tetrachloride results in increased expression of CXCL14 mRNA CTD PMID:17484886 more ... tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CXCL14 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:1316587 6480464 CXCL14 mRNA promotes the reaction [Carbon Tetrachloride results in decreased expression of MIR200A mRNA] more ... CTD PMID:33069761 titanium dioxide multiple interactions ISO RGD:1316587 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL14 mRNA CTD PMID:29950665 toluene decreases expression EXP 6480464 Toluene results in decreased expression of CXCL14 mRNA CTD PMID:22967744 tributylstannane increases expression ISO RGD:1316587 6480464 tributyltin results in increased expression of CXCL14 mRNA CTD PMID:31939706 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CXCL14 mRNA CTD PMID:33387578 trichostatin A decreases acetylation ISO RGD:1316586 6480464 trichostatin A results in decreased acetylation of CXCL14 protein CTD PMID:20562917 trichostatin A multiple interactions ISO RGD:1316586 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA CTD PMID:27188386 trichostatin A decreases expression ISO RGD:1316586 6480464 trichostatin A results in decreased expression of CXCL14 mRNA CTD PMID:26705709 trichostatin A increases expression ISO RGD:1316586 6480464 trichostatin A results in increased expression of CXCL14 mRNA CTD PMID:24935251 , PMID:26272509 valproic acid decreases methylation ISO RGD:1316586 6480464 Valproic Acid results in decreased methylation of CXCL14 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1316586 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1316586 6480464 Valproic Acid results in increased expression of CXCL14 mRNA CTD PMID:23179753 more ... valproic acid decreases expression ISO RGD:1316586 6480464 Valproic Acid results in decreased expression of CXCL14 mRNA CTD PMID:23179753 , PMID:28001369 vorinostat increases expression ISO RGD:1316586 6480464 vorinostat results in increased expression of CXCL14 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:1316586 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA CTD PMID:27188386 zinc dichloride increases expression ISO RGD:1316586 6480464 zinc chloride results in increased expression of CXCL14 mRNA CTD PMID:19428942 zoledronic acid decreases expression ISO RGD:1316586 6480464 zoledronic acid results in decreased expression of CXCL14 mRNA CTD PMID:24714768